马斯克旗下脑机接口公司，最新进展！6月初刚获6.5亿美元融资

Core Insights - Neuralink has demonstrated significant advancements in brain-machine interface (BMI) technology, with 7 patients currently implanted with their N1 device, enabling them to control computers using their thoughts [1][2] - The global market for brain-machine interfaces is projected to grow from $1.98 billion in 2023 to over $6 billion by 2028, with a compound annual growth rate (CAGR) of 25.22% [2] - The Chinese market for brain-machine interfaces is expected to exceed 120 billion yuan by 2040, with an average annual growth rate of approximately 26% [2] Company Developments - Neuralink has completed a $650 million Series E funding round, with major investors including Ark Invest, DFJ Growth, Founders Fund, Lightspeed Venture Partners, Sequoia Capital, and Xingsheng Capital [1] - The company has initiated clinical trials in top neurosurgical institutions across the U.S., Canada, and the UAE, significantly increasing investment to expand the number of neurons and brain regions that devices can connect to [2] Industry Trends - The brain-machine interface technology is categorized into invasive, semi-invasive, and non-invasive types, with non-invasive interfaces currently dominating the market, holding an 86% share [3] - Recent supportive policies in China are expected to accelerate the development of the brain-machine interface industry, including the establishment of national standards for non-invasive medical devices [4][5] - The Shanghai and Beijing action plans aim to cultivate leading technology enterprises and promote the commercialization of brain-machine interface products across various sectors by 2030 [5][6]